Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2882-2889

  Stankov, Metodi V ^a   Schmidt, Reinhold E ^a   Behrens, Georg M N ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAVUDINE; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; ZALCITABINE; ZIDOVUDINE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; ASSAY; CELL CLONE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID STORAGE; LIPOATROPHY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TISSUE REGENERATION;

3T3 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION; HUMANS; MICE; PPAR GAMMA; REVERSE TRANSCRIPTASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAVUDINE; TRIGLYCERIDES; ZIDOVUDINE;

EID: 48749099654     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01505-07     Document Type: Article

References (46)

1. Ahmed Ouameur, A., R. Marty, J. F. Neault, and H. A. Tajmir-Riahi. 2004. AZT binds RNA at multiple sites. DNA Cell Biol. 23:783-788.
2. Ahmed-Ouameur, A., J. F. Neault, S. Claveau, and H. A. Tajmir-Riahi. 2005. AZT binding to Na,K-ATPase. Cell Biochem. Biophys. 42:87-94.
3. Ailhaud, G., P. Grimaldi, and R. Negrel. 1992. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12:207-233.
4. Amri, E. Z., C. Dani, A. Doglio, J. Etienne, P. Grimaldi, and G. Ailhaud. 1986. Adipose cell differentiation: evidence for a two-step process in the polyamine-dependent Ob1754 clonal line. Biochem. J. 238:115-122.
5. Amri, E. Z., C. Dani, A. Doglio, P. Grimaldi, and G. Ailhaud. 1986. Coupling of growth arrest and expression of early markers during adipose conversion of preadipocyte cell lines. Biochem. Biophys. Res. Commun. 137:903-910.
6. Brinkman, K., J. A. Smeitink, J. A. Romijn, and P. Reiss. 1999. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354:1112-1115.
7. Brinkman, K., H. J. ter Hofstede, D. M. Burger, J. A. Smeitink, and P. P. Koopmans. 1998. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12:1735-1744.
8. Brun, R. P., J. B. Kim, E. Hu, S. Altiok, and B. M. Spiegelman. 1996. Adipocyte differentiation: a transcriptional regulatory cascade. Curr. Opin. Cell Biol. 8:826-832.
9. Burger, D. M., H. Rosing, C. H. ten Napel, T. Duyts, P. L. Meenhorst, J. W. Mulder, C. H. Koks, A. Bult, and J. H. Beijnen. 1994. Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid. Antimicrob. Agents Chemother. 38:2763-2767.
10. Caron, M., M. Auclair, C. Lagathu, A. Lombes, U. A. Walker, M. Kornprobst, and J. Capeau. 2004. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS 18:2127-2136.
11. Caron, M., M. Auclair, C. Vigoureux, M. Glorian, C. Forest, and J. Capeau. 2001. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 50:1378-1388.
12. Cazzalini, O., M. C. Lazze, L. Iamele, L. A. Stivala, L. Bianchi, P. Vaghi, A. Cornaglia, A. Calligaro, D. Curti, A. Alessandrini, E. Prosperi, and V. Vannini. 2001. Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes. Biochem. Pharmacol. 62:893-902.
13. Clarke, S. L., C. E. Robinson, and J. M. Gimble. 1997. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochem. Biophys. Res. Commun. 240:99-103.
14. Cote, H. C. 2005. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy. Antivir. Ther. 10:M3-M11.
15. Gorzelniak, K., J. Janke, S. Engeli, and A. M. Sharma. 2001. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm. Metab. Res. 33:625-627.
16. Gougeon, M. L., L. Penicaud, B. Fromenty, P. Leclercq, J. P. Viard, and J. Capeau. 2004. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir. Ther. 9:161-177.
17. Green, H., and O. Kehinde. 1976. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105-113.
18. Gregoire, F. M. 2001. Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. (Maywood) 226:997-1002.
19. Izbicka, E., D. Nishioka, V. Marcell, E. Raymond, K. K. Davidson, R. A. Lawrence, R. T. Wheelhouse, L. H. Hurley, R. S. Wu, and D. D. Von Hoff. 1999. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos. Anticancer Drug Des. 14:355-365.
20. Janneh, O., P. G. Hoggard, J. F. Tjia, S. P. Jones, S. H. Khoo, B. Maher, D. J. Back, and M. Pirmohamed. 2003. Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes. Antivir. Ther. 8:417-426.
21. Kuri-Harcuch, W., and M. Marsch-Moreno. 1983. DNA synthesis and cell division related to adipose differentiation of 3T3 cells. J. Cell. Physiol. 114:39-44.
22. Lee, H., J. Hanes, and K. A. Johnson. 2003. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 42:14711-14719.
23. Lewis, W. 2005. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antivir. Ther. 10:M13-M27.
24. Lewis, W. 2003. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions. Antivir. Res. 58:189-197.
25. Lewis, W., B. J. Day, and W. C. Copeland. 2003. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat. Rev. Drug Discov. 2:812-822.
26. MacDougald, O. A., and M. D. Lane. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:345-373.
27. Mandrup, S., and M. D. Lane. 1997. Regulating adipogenesis. J. Biol. Chem. 272:5367-5370.
28. Marty, R., A. A. Ouameur, J. F. Neault, S. Nafisi, and H. A. Tajmir-Riahi. 2004. AZT-DNA interaction. DNA Cell Biol. 23:135-140.
29. Nolan, D., E. Hammond, I. James, E. McKinnon, and S. Mallal. 2003. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir. Ther. 8:617-626.
30. Nolan, D., E. Hammond, A. Martin, L. Taylor, S. Herrmann, E. McKinnon, C. Metcalf, B. Latham, and S. Mallal. 2003. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 17:1329-1338.
31. Pairault, J., and H. Green. 1979. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc. Natl. Acad. Sci. USA 76:5138-5142.
32. Pinti, M., P. Salomoni, and A. Cossarizza. 2006. Anti-HIV drugs and the mitochondria. Biochim. Biophys. Acta 1757:700-707.
33. Rha, S. Y., E. Izbicka, R. Lawrence, K. Davidson, D. Sun, M. P. Moyer, G. D. Roodman, L. Hurley, and D. Von Hoff. 2000. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin. Cancer Res. 6:987-993.
34. Roskrow, M., and S. N. Wickramasinghe. 1990. Acute effects of 3′-azido-3′-deoxythymidine on the cell cycle of HL60 cells. Clin. Lab. Haematol. 12:177-184.
35. Spiegelman, B. M., and S. R. Farmer. 1982. Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell 29:53-60.
36. Stankov, M. V., T. Lucke, A. M. Das, R. E. Schmidt, and G. M. Behrens. 2007. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir. Ther. 12:205-216.
37. Sutinen, J., E. Korsheninnikova, T. Funahashi, Y. Matsuzawa, T. Nyman, and H. Yki-Jarvinen. 2003. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J. Clin. Endocrinol. Metab. 88:1907-1910.
38. Tang, Q. Q., and M. D. Lane. 1999. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 13:2231-2241.
39. Tang, Q. Q., T. C. Otto, and M. D. Lane. 2003. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 100:44-49.
40. Viengchareun, S., M. Caron, M. Auclair, M. J. Kim, P. Frachon, J. Capeau, M. Lombes, and A. Lombes. 2007. Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes. Antivir. Ther. 12:919-929.
41. Waclawik, A. J., J. Vann, G. Schmelz, P. Szurek, P. Lewandoski, and B. R. Brooks. 1999. Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus. Neurotoxicology 20:49-56.
42. Wang, L. H., G. E. Chittick, and J. A. McDowell. 1999. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection. Antimicrob. Agents Chemother. 43:1708-1715.
43. Wiesner, J. L., F. C. Sutherland, M. J. Smit, G. H. van Essen, H. K. Hundt, K. J. Swart, and A. F. Hundt. 2002. Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of stavudine in human plasma. J. Chromatogr. B 773:129-134.
44. Yeh, W. C., B. E. Bierer, and S. L. McKnight. 1995. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc. Natl. Acad. Sci. USA 92:11086-11090.
45. Zuk, P. A., M. Zhu, P. Ashjian, D. A. De Ugarte, J. I. Huang, H. Mizuno, Z. C. Alfonso, J. K. Fraser, P. Benhaim, and M. H. Hedrick. 2002. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13:4279-4295.
46. Zuk, P. A., M. Zhu, H. Mizuno, J. Huang, J. W. Futrell, A. J. Katz, P. Benhaim, H. P. Lorenz, and M. H. Hedrick. 2001. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:211-228.